Related Experiment Video
Updated: Aug 8, 2026
From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
Histopathology, pathogenesis and molecular genetics in primary central nervous system lymphomas
M Nakamura1, K Shimada, E Ishida
1Department of Pathology, Nara Medical University, Nara, Japan.
Insights
Primary central nervous system lymphoma (PCNSL) incidence is rising in all patients. This review details PCNSL epidemiology, genetics, and pathogenesis in immunocompetent individuals to guide therapy development.
Area of Science:
- Oncology
- Neurology
- Immunology
Background:
- Primary central nervous system lymphoma (PCNSL) is a rare non-Hodgkin's lymphoma originating in the brain.
- Recent increases in PCNSL incidence are observed in both immunodeficient and immunocompetent populations.
- The molecular and cytogenetic biology of PCNSL remains less characterized than lymphomas outside the central nervous system.
Purpose of the Study:
- To review the epidemiology, clinical aspects, histopathology, pathogenesis, and molecular genetics of PCNSL.
- To focus specifically on PCNSL in immunocompetent patients.
- To provide a foundation for developing effective therapies for this aggressive lymphoma.
Main Methods:
- Literature review of epidemiological data.
- Analysis of clinical presentations and histopathological findings.
- Examination of current understanding of PCNSL pathogenesis and molecular genetics.
Main Results:
- PCNSL incidence is increasing, particularly in immunocompetent individuals.
- Understanding PCNSL biology is crucial for therapeutic advancements.
- This review consolidates current knowledge on PCNSL in immunocompetent hosts.
Conclusions:
- Further research into PCNSL's molecular and cytogenetic underpinnings is essential.
- A comprehensive understanding of PCNSL is needed to improve treatment strategies.
- Targeted therapies may be developed by elucidating the pathogenesis of PCNSL in immunocompetent patients.
Abstract:
Recent increases in the incidence of primary central nervous system lymphoma (PCNSL), a rare non-Hodgkin's lymphoma arising in the brain, have been noted in both immunodeficient and immunocompetent patients. Compared with lymphomas originating outside the central nervous system, the biology of PCNSL at the molecular or cytogenetic level has not been well characterized, yet it is important to thoroughly understand the etiology of this rare malignant lymphoma if effective therapies are to be developed. This review will focus on the epidemiology, clinical aspects, histopathology, pathogenesis, and molecular genetics of this aggressive, extranodal lymphoma in immunocompetent patients.
More Related Videos
09:33Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
Published on: August 25, 2023
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
